DifizmaIndacaterol + Glycopyrrolate + Mometasone
Difizma is marketed by Lupin. 1 pack on NPPA's price list for July 2026, containing Indacaterol + Glycopyrrolate + Mometasone.
- Packs listed
- 1
- Lowest MRP
- ₹393.00
- Per unit
- ₹39.30
- Price-controlled packs
- 0 of 1
- Dosage forms
- 1
Packs and prices
- ₹393.00Difizma 173/63/160 mcg Capsule 10Indacaterol + Glycopyrrolate + Mometasone Capsule 173/63/160 mcg · ₹39.30 per capsule
The company
Lupin has 1,897 packs on the price list, and CDSCO has named it as the manufacturer of 9 failed batches since Jun 2014. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.